|
|
|||
|
||||
OverviewThis important book provides up-to-date information on a series of topical issues relating to the approach to minimal residual disease in breast cancer patients. It first explains how the study of minimal residual disease and circulating and disseminated tumor cells (CTCs/DTCs) can assist in the understanding of breast cancer metastasis. A series of chapters then discuss the various technologies available for the detection and characterization of CTCs and DTCs, pinpointing their merits and limitations. Detailed consideration is given to the relevance of CTCs and DTCs, and their detection, to clinical research and practice. The role of other blood-based biomarkers is also addressed, and the closing chapters debate the challenges facing drug and biomarker co-development and the use of CTCs for companion diagnostic development. This book will be of interest and assistance to all who are engaged in the modern management of breast cancer. Full Product DetailsAuthor: Michail Ignatiadis , Christos Sotiriou , Klaus PantelPublisher: Springer-Verlag Berlin and Heidelberg GmbH & Co. KG Imprint: Springer-Verlag Berlin and Heidelberg GmbH & Co. K Edition: 2012 ed. Volume: 195 Dimensions: Width: 15.50cm , Height: 2.00cm , Length: 23.50cm Weight: 0.571kg ISBN: 9783642281594ISBN 10: 3642281591 Pages: 254 Publication Date: 23 April 2012 Audience: Professional and scholarly , Professional & Vocational Format: Hardback Publisher's Status: Active Availability: Manufactured on demand We will order this item for you from a manufactured on demand supplier. Table of ContentsReviewsFrom the reviews: This book is aimed directly at cancer researchers, delving into the various technologies used to identify and characterize these rare tumor cells. ... this is the first book to summarize the progress in this field. It charts the evolution in thinking about breast cancer from the Halstedian notion of a local disease to more of a systemic illness in an accessible way and nicely summarizes the data without overwhelming readers. (Megan E. Sullivan, Doody's Review Service, July, 2012) From the reviews: This book is aimed directly at cancer researchers, delving into the various technologies used to identify and characterize these rare tumor cells. ... this is the first book to summarize the progress in this field. It charts the evolution in thinking about breast cancer from the Halstedian notion of a local disease to more of a systemic illness in an accessible way and nicely summarizes the data without overwhelming readers. (Megan E. Sullivan, Doody's Review Service, July, 2012) Author InformationTab Content 6Author Website:Countries AvailableAll regions |
||||